2684 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 11
00:58 UTC
|
SPB
Spectrum Brands
|
↓ Downgrade | Nik Modi ★★★★★ #190 | Outperform→ Sector Perform | $85.00→ $92.00+8.2% |
|
Aug 11
00:58 UTC
|
SION
Sionna Therapeutics
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Aug 11
00:58 UTC
|
SION
Sionna Therapeutics
|
↓ Downgrade | Kambiz Yazdi ★★★☆☆ #1170 | Buy→ Neutral | |
|
Aug 11
00:58 UTC
|
SION
Sionna Therapeutics
|
↓ Downgrade | Jonathan Wolleben ★★★★☆ #890 | Mkt Outperform→ Market Perform | |
|
Aug 11
00:58 UTC
|
SION
Sionna Therapeutics
|
↓ Downgrade | Chris Raymond not yet tracked | Strong-Buy→ Market Perform | |
|
Aug 11
00:58 UTC
|
RUS
Russel Metals
|
↓ Downgrade | firm only | Outperform→ Market Perform | C$70.00→ C$82.00+17.1% |
|
Aug 11
00:58 UTC
|
MPLT
Maplight Therapeutics
|
↓ Downgrade | Ashwani Verma ★★★★★ #105 | Buy→ Neutral | $52.00→ $13.00-75.0% |
|
Aug 11
00:58 UTC
|
MNDY
monday.com
|
↓ Downgrade | Thomas Blakey ★★★★★ #296 | Overweight→ Neutral | $90.00 |
|
Aug 11
00:58 UTC
|
MNDY
monday.com
|
↓ Downgrade | firm only | Overweight→ Equal Weight | $95.00 |
|
Aug 11
00:58 UTC
|
LGEN
Legal & General Group
|
↓ Downgrade | firm only | Sell | GBX 251→ GBX 245-2.4% |
|
Aug 11
00:58 UTC
|
KMT
Kennametal
|
↓ Downgrade | Angel Castillo ★★★☆☆ #2064 | Equal Weight→ Underweight | $31.00→ $27.00-12.9% |
|
Aug 11
00:58 UTC
|
JWEL
Jamieson Wellness
|
↓ Downgrade | firm only | Buy→ Hold | C$44.50→ C$45.75+2.8% |
|
Aug 11
00:58 UTC
|
JWEL
Jamieson Wellness
|
↓ Downgrade | firm only | Outperform→ Sector Perform | C$46.00→ C$45.75-0.5% |
|
Aug 11
00:58 UTC
|
JWEL
Jamieson Wellness
|
↓ Downgrade | firm only | Buy→ Hold | C$48.00→ C$49.00+2.1% |
|
Aug 11
00:58 UTC
|
IPAR
Interparfums
|
↓ Downgrade | Aron Adamski ★★★☆☆ #1423 | Buy→ Neutral | $110.00→ $129.00+17.3% |
|
Aug 11
00:58 UTC
|
IPAR
Interparfums
|
↓ Downgrade | Jonna Kim ★★★★★ #234 | Buy→ Hold | $110.00→ $120.00+9.1% |
|
Aug 11
00:58 UTC
|
IIIV
i3 Verticals
|
↓ Downgrade | Mark Palmer ★★★★☆ #551 | Buy→ Hold | |
|
Aug 11
00:58 UTC
|
HZO
MarineMax
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Aug 11
00:58 UTC
|
GGB
Gerdau
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Aug 11
00:58 UTC
|
DOCS
Doximity
|
↓ Downgrade | Stan Berenshteyn ★★★★★ #184 | Equal Weight→ Underweight | $18.00 |
|
Aug 11
00:58 UTC
|
CHMI
Cherry Hill Mortgage Investment
|
↓ Downgrade | firm only | Neutral | |
|
Aug 11
00:58 UTC
|
CGNX
Cognex
|
↓ Downgrade | Helen Fang ★★★☆☆ #1347 | Buy→ Hold | $65.00 |
|
Aug 11
00:58 UTC
|
CF
Canaccord Genuity Group
|
↓ Downgrade | firm only | Strong-Buy→ Outperform | |
|
Aug 11
00:58 UTC
|
CCHGY
Coca-Cola HBC
|
↓ Downgrade | firm only | Neutral | |
|
Aug 11
00:58 UTC
|
CC
Chemours
|
↓ Downgrade | Joshua Spector ★★★☆☆ #1180 | Buy→ Neutral | $18.00 |
|
Aug 11
00:58 UTC
|
BWMN
Bowman Consulting Group
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Aug 11
00:58 UTC
|
BLFS
BioLife Solutions
|
↓ Downgrade | Robert Wasserman ★★★☆☆ #1358 | Buy→ Hold | |
|
Aug 11
00:58 UTC
|
ATS
ATS
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Aug 11
00:58 UTC
|
ATS
ATS
|
↓ Downgrade | firm only | Buy→ Hold | C$49.00→ C$33.00-32.7% |
|
Aug 11
00:58 UTC
|
ARKO
ARKO
|
↓ Downgrade | Bobby Griffin ★★★★☆ #729 | Strong-Buy→ Outperform | $8.00→ $7.00-12.5% |
|
Aug 11
00:58 UTC
|
AMRZ
Amrize
|
↓ Downgrade | Anthony Codling ★★★☆☆ #1835 | Sec→ r Perform ➝ Underperform | $60.00→ $48.00-20.0% |
|
Aug 11
00:58 UTC
|
ACH
Accendra Health
|
↓ Downgrade | Daniel Grosslight ★★★☆☆ #1075 | Buy→ Neutral | |
|
Aug 11
00:58 UTC
|
AAPL
Apple
|
↓ Downgrade | Edison Lee ★★☆☆☆ #2254 | Buy→ Underperform | $285.56→ $263.66-7.7% |
|
Aug 10
23:58 UTC
|
MNDY
monday.com
|
↓ Downgrade | Thomas Blakey ★★★★★ #296 | Overweight→ Neutral | $90.00 |
|
Aug 10
22:58 UTC
|
VREX
Varex Imaging
|
↓ Downgrade | firm only | Market Perform | |
|
Aug 10
22:58 UTC
|
MNDY
monday.com
|
↓ Downgrade | Thomas Blakey ★★★★★ #296 | Overweight→ Neutral | |
|
Aug 10
22:58 UTC
|
ACH
Accendra Health
|
↓ Downgrade | Daniel Grosslight ★★★☆☆ #1075 | Buy→ Neutral | |
|
Aug 10
20:57 UTC
|
TENX
Tenax Therapeutics
|
↓ Downgrade | Matt Phipps ★★★★☆ #786 | Outperform→ Market Perform | |
|
Aug 10
20:57 UTC
|
SION
Sionna Therapeutics
|
↓ Downgrade | Kambiz Yazdi ★★★☆☆ #1170 | Buy→ Neutral | |
|
Aug 10
19:57 UTC
|
MPLT
Maplight Therapeutics
|
↓ Downgrade | Ashwani Verma ★★★★★ #105 | Buy→ Neutral | $52.00→ $13.00-75.0% |
|
Aug 10
18:57 UTC
|
TENX
Tenax Therapeutics
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Aug 10
18:57 UTC
|
SPB
Superior Plus
|
↓ Downgrade | firm only | Outperform→ Sector Perform | C$10.00→ C$9.00-10.0% |
|
Aug 10
18:57 UTC
|
SION
Sionna Therapeutics
|
↓ Downgrade | Jonathan Wolleben ★★★★☆ #890 | Mkt Outperform→ Market Perform | |
|
Aug 10
18:57 UTC
|
RUS
Russel Metals
|
↓ Downgrade | firm only | Outperform→ Market Perform | C$70.00→ C$82.00+17.1% |
|
Aug 10
18:57 UTC
|
MNDY
monday.com
|
↓ Downgrade | firm only | Overweight→ Equal Weight | $95.00 |
|
Aug 10
18:57 UTC
|
JWEL
Jamieson Wellness
|
↓ Downgrade | firm only | Buy→ Hold | C$44.50→ C$45.75+2.8% |
|
Aug 10
18:57 UTC
|
JWEL
Jamieson Wellness
|
↓ Downgrade | firm only | Outperform→ Sector Perform | C$46.00→ C$45.75-0.5% |
|
Aug 10
18:57 UTC
|
JWEL
Jamieson Wellness
|
↓ Downgrade | firm only | Buy→ Hold | C$48.00→ C$49.00+2.1% |
|
Aug 10
18:57 UTC
|
CF
Canaccord Genuity Group
|
↓ Downgrade | firm only | Strong-Buy→ Outperform | |
|
Aug 10
18:57 UTC
|
ATS
ATS
|
↓ Downgrade | firm only | Buy→ Hold | C$49.00→ C$33.00-32.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.